These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15254599)

  • 1. Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence.
    Viktrup L; Pangallo BA; Detke MJ; Zinner NR
    Prim Care Companion J Clin Psychiatry; 2004; 6(2):65-73. PubMed ID: 15254599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or Hypomania.
    Viktrup L; Perahia DG; Tylee A
    Prim Care Companion J Clin Psychiatry; 2004; 6(6):239-243. PubMed ID: 15614311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine for the treatment of post-prostatectomy stress urinary incontinence.
    Neff D; Guise A; Guralnick ML; Langenstroer P; See WA; Jacobsohn KM; O'Connor RC
    Can Urol Assoc J; 2013; 7(5-6):E260-2. PubMed ID: 23766826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.
    Brunenberg DE; Joore MA; Veraart CP; Berghmans BC; van der Vaart CH; Severens JL
    Clin Ther; 2006 Apr; 28(4):604-18. PubMed ID: 16750472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do we know about duloxetine's mode of action? Evidence from animals to humans.
    Schuessler B
    BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
    J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine in the treatment of stress urinary incontinence.
    Jost WH; Marsalek P
    Ther Clin Risk Manag; 2005 Dec; 1(4):259-64. PubMed ID: 18360568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.
    Baessler K; Christmann-Schmid C; Maher C; Haya N; Crawford TJ; Brown J
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013108. PubMed ID: 30121956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany.
    Manning M; Gotsch U; Minarzyk A; Quail D; Gross A; Pages I; Methfessel HD; Michel MC
    Int J Clin Pract; 2009 Dec; 63(12):1724-33. PubMed ID: 19930333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for stress urinary incontinence : present and future options.
    Zinner NR; Koke SC; Viktrup L
    Drugs; 2004; 64(14):1503-16. PubMed ID: 15233589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of duloxetine in women with stress urinary incontinence.
    Bump RC; Voss S; Beardsworth A; Manning M; Zhao YD; Chen W
    BJU Int; 2008 Jul; 102(2):214-8. PubMed ID: 18422764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
    Alberti C
    G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of stress urinary incontinence with duloxetine hydrochloride.
    Sweeney DD; Chancellor MB
    Rev Urol; 2005; 7(2):81-6. PubMed ID: 16985814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.